FDA Committee Weighs in on Pfizer’s mRNA Vaccine

Despite the red flags in the clinical trials (such as increased intensity of “side effects” after the second dose), the grave concerns increasingly being presented by doctors and scientists about the experimental mRNA vaccines, the spike protein, the lipid nanoparticles, the PEG; despite lack of necessity (treatments exist) and the absence of adequate effectiveness and safety data – the FDA’s Vaccine and Related Biological Products Advisory Committee (VRBPAC) said “Yes” to the following question:

“Based on the totality of scientific evidence available, do the benefits of the Pfizer-BioNTech COVID-19 Vaccine outweigh its risk for us in individuals 16 years of age and older.”

The vote was 17 yes, 4 no, and 1 abstained.

This is the danger of products that are liability-free for the manufacturers and for the agencies that are making decisions about them. It is disturbing to see how the majority of them are willing to send experimental products out into the general public to watch and see what happens.

Link to Page with Meeting Documents

Full 8+ hour meeting below.

Print Friendly, PDF & Email
close

Like what you learned? Subscribe to our Feed to get email notice of new posts.

Get new posts by email: